<DOC>
	<DOCNO>NCT00086645</DOCNO>
	<brief_summary>This study determine efficacy safety citalopram compare placebo treatment child autism .</brief_summary>
	<brief_title>Citalopram Children With Autism Repetitive Behavior ( STAART Study 1 )</brief_title>
	<detailed_description>For child autism spectrum disorder ( ASD , also know Pervasive Developmental Disorders - PDDs ) , repetitive behavior common frequently interfere function home well social educational setting . These behavior may involve repetitive movement , rigid routine , repetitive play , even repetitive speech . These behavior may associate high level anxiety , severe tantrum . Self-injury occur behavior routine interrupt . Participants randomly assign receive citalopram placebo ( administer liquid ) , carefully follow every two week . At end 12 week , child respond treatment give opportunity continue study , monthly visit , additional 24 week . Children receive placebo respond treatment 12 week give opportunity receive carefully monitor 12 week course citalopram .</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Able walk Diagnosis Autistic Disorder , Asperger 's Disorder , PDDNOS Have score great equal ( &gt; ) 8 sum item 1A , 2 , 3 5 Compulsions Subscale Revised CYBOCS . Have rating least moderate behavioral disturbance base modified Clinical Global ImpressionSeverity Illness score ( CGIS ) time screen ( See description ) . Be free psychotropic medication least one month fluoxetine , two week SSRIs neuroleptic , 5 day stimulant prior baseline rating . Be judge reliable medication compliance agree keep appointment study contact test outline protocol ( subject guardian ( ) ) . Medical contraindication therapy SSRIs Prior exposure citalopram ( escitalopram ) sufficient dose duration determine response status History treatment failure clinically adequate trial two select SSRIs Diagnosis Rett 's Disorder Childhood Disintegrative Disorder Uncontrolled epilepsy , seizure within past 6 month Child weigh less ( &lt; ) 15 kg screen contact . Pregnancy Presence chronic medical condition might interfere study participation study participation would contraindicate Clinically significant abnormal baseline laboratory test History bipolar disorder manic episode induce antidepressant exposure Documented need ongoing psychotropic medication besides study medication ( exception stable dose ( least 3 month ) anticonvulsants seizure ) . Concomitant medication would interfere participation study . Recent ( &lt; 2 month ) initiation behavior therapy ( parent training , apply behavior analysis behavior modification ) clinic , private practitioner school program . Participants establish behavior therapy program ( define great ( &gt; ) 2 month clinic private practitioner great ( &gt; ) 1 month school program ) include study . Families ask initiate new behavior therapy study .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Autism</keyword>
	<keyword>Asperger Syndrome</keyword>
	<keyword>Pervasive Developmental Disorder</keyword>
	<keyword>PDD</keyword>
	<keyword>Rituals</keyword>
	<keyword>Compulsions</keyword>
	<keyword>Stereotypy</keyword>
	<keyword>Routines</keyword>
	<keyword>Repetitive behavior</keyword>
	<keyword>SSRI</keyword>
	<keyword>Serotonin</keyword>
</DOC>